Feedback / Questions
bonretinib (OB756) - Biosun Pharma
https://www.onclive.com/view/ob756-showcases-favorable-tolerability-in-jak-inhibitor-naive-myelofibrosis
Dec 16, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next